H.C. Wainwright adjusted the firm’s price target on Arqit Quantum (ARQQ) to $22 from $2 and keeps a Buy rating on the shares to reflect the ...
H.C. Wainwright raised the firm’s price target on Iris Energy (IREN) to $16 from $13 and keeps a Buy rating on the shares. The company is ...
H.C. Wainwright has recently reduced Eyenovia Inc (EYEN) stock to Neutral rating, as announced on November 18, 2024, according to Finviz. Earlier, on March 1, 2021, Northland Capital had initiated the ...
WARMINSTER, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage ...
H.C. Wainwright analyst Andrew Fein lowered the firm’s price target on Alector (ALEC) to $7 from $35 and keeps a Buy rating ...
H.C. Wainwright lowered the firm’s price target on Invivyd (IVVD) to $10 from $15 and keeps a Buy rating on the shares following the Q3 report. The firm expects expect the launch of Pemgarda ...
H.C. Wainwright initiated coverage of Vanda Pharmaceuticals (NASDAQ:VNDA) with a buy rating, citing its negative enterprise value. The investment bank said its rating was based on Vanda’s well ...
H.C. Wainwright placed the firm’s Buy rating on Ocuphire Pharma (OCUP) under review saying the acquisition of Opus Genetics starts a new chapter. The views and opinions expressed herein are the ...
Number 1 Investment Bank for Confidentially Marketed Public Offerings, Registered Direct, Private Placement, and At-the-Market (ATM) Offerings H.C. Wainwright & Co., LLC, announced its #1 Ranking ...
We recently compiled a list of the 15 AI News That Should Not Be Ignored. In this article, we are going to take a look at where Spectral AI, Inc. (NASDAQ:MDAI) stands against the other AI stocks ...
Phunware (NASDAQ:PHUN) shares retreated 11% in Tuesday late morning trading after H.C. Wainwright & Co. downgraded the application software company to Neutral from Buy, as analyst Scott Buck ...
NEW YORK--(BUSINESS WIRE)--H.C. Wainwright & Co., LLC, announced its #1 Ranking by transaction volume during the third quarter of 2024, maintaining the Firm’s top position for 38 consecutive ...